![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1394, 2012-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Tyagi Pradeep Tyagi Vikas Chancellor Michael
Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibody therapy phase I trial safety remains topical
Reactions Weekly, Vol. 1, Iss. 1121, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibody therapy phase I trial safety remains topical
Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Factor VIII gene therapy: promising phase I results in haemophilia A
Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. :